Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Receives Average Rating of "Moderate Buy" from Brokerages
Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE - Get Free Report) has received an average rating of "Moderate Buy" from the six ratings firms that are covering the stock, Marketbeat Ratings reports. One...